HEM Pharma

376270 · KOSDAQ · ₩376270 · HEM파마

₩26,200▲ ₩50 (0.19%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩13B₩15B₩5.3B₩3.7B₩1.9B
Cost of sales₩12B₩13B₩4.5B₩3B₩1.4B
Gross profit₩632M₩1.6B₩801M₩623M₩487M
Operating income−₩16B−₩7.7B−₩12B−₩13B−₩11B
Net income−₩24B−₩7.6B−₩12B−₩13B−₩11B
Net income to shareholders−₩24B−₩7.6B−₩12B−₩13B−₩11B

Balance sheet

20252024202320222021
Total assets₩52B₩37B₩28B₩35B₩27B
Current assets₩23B₩17B₩11B₩23B₩16B
Cash and equivalents₩14B₩6.3B₩8.2B₩2.2B₩11B
Total liabilities₩47B₩11B₩10B₩15B₩5.7B
Current liabilities₩40B₩9.1B₩8.6B₩14B₩1.5B
Borrowings₩17B₩6.5B₩6.5B₩12B₩3.3B
Total equity₩5.2B₩26B₩17B₩20B₩21B
Shareholders' equity₩5B₩26B₩17B₩20B₩21B

Cash flow

20252024202320222021
Cash from operations−₩8.3B−₩7.7B−₩5.3B−₩11B−₩7.5B
Capital spending−₩9.8B₩4.7B₩4.5B₩10B₩6.8B
Free cash flow−₩18B−₩12B−₩9.8B−₩21B−₩14B

Consolidated where available. Amounts in won.

Also known as: HEM Pharma / HEM파마 / 376270 / KRX:376270

Source: KRX statistical information